馃嚞馃嚟GhanaWeb路6 hours ago
HPV vaccine significantly reduces cervical cancer deaths in young women, research shows
New research indicates that children vaccinated against HPV at ages 12-13 have a near-zero risk of dying from cervical cancer before age 30. This landmark study, the first of its kind, reveals a sharp decline in deaths since school-aged girls in England began receiving the vaccine in 2008, saving approximately 200 lives to date. Between 2020 and 2024, no cervical cancer deaths were recorded in women aged 20 to 24, a first for a five-year period. Professor Peter Sasieni, lead researcher at Queen Mary University of London, noted the vaccine's ability to almost eliminate a specific type of cancer. While cervical cancer remains the 14th most common cancer among females in the UK, with 3,300 diagnoses annually, HPV is believed to cause 99% of these cases. Cancer Research UK, which funded the study, called the findings an "incredible milestone" but highlighted that vaccination rates in England are below recommended levels. The UK government aims to eliminate cervical cancer as a public health problem by 2040, but 2024-25 data shows only 76% of girls in England were vaccinated by age 15, short of the World Health Organization's 90% target. Boys have also received the HPV vaccine since 2019 to protect against various cancers and reduce virus transmission. The Department of Health and Social Care in England acknowledged the vaccine's "extraordinary impact" and is working to boost uptake.